Cite
HARVARD Citation
Xie, L. et al. (2018). Cost‐effectiveness of antiviral treatment after resection in hepatitis B virus–related hepatocellular carcinoma patients with compensated cirrhosis. Hepatology. 68 (4), pp. 1476-1486. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, L. et al. (2018). Cost‐effectiveness of antiviral treatment after resection in hepatitis B virus–related hepatocellular carcinoma patients with compensated cirrhosis. Hepatology. 68 (4), pp. 1476-1486. [Online].